Lived experience experts: a name created by us for us
Author:
Affiliation:
1. Patient Author, Lived Experience Expert, Chicago, Il, USA
2. National Hemophilia Foundation, New York, NY, USA
3. Patient Author, Lived Experience Expert, Pasadena, CA, USA
4. Hemophilia Foundation of Southern California, Pasadena, CA, USA
Funder
the National Hemophilia Foundation
Publisher
Informa UK Limited
Subject
Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/17474086.2023.2178410
Reference26 articles.
1. The Patient-as-Partner Approach in Health Care
2. A Model for a Regional System of Care to Promote the Health and Well-Being of People with Rare Chronic Genetic Disorders
3. Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians
4. National Institutes of Health. NIH clinical center patient handbook [cited 2022 Dec 11]. Available from: https://clinicalcenter.nih.gov/sites/nihinternet/files/internet-files/participate/_pdf/pthandbook.pdf.
5. U.S. Food and Drug Administration. FDA patient engagement overview [cited 2022 Dec 13]. Available from: https://www.fda.gov/patients/learn-about-fda-patient-engagement/fda-patient-engagement-overview.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. “Our children are the forgotten children”: Experiences of COVID-19 asymptomatic testing in young people with Special Educational Needs and Disabilities and those who care for them;2024-09-03
2. Expert Panels in Evaluation: An Update From the Field Using the DATA Model;Canadian Journal of Program Evaluation;2024-06-01
3. Implementation outcomes of the Philadelphia Police School Diversion Program: A school-based alternative-to-arrest initiative;Journal of Crime and Justice;2024-05-21
4. Race and ethnicity reporting and representation in hemophilia clinical trials;Blood Advances;2024-05-17
5. The growing research toolbox for SLC13A5 citrate transporter disorder: a rare disease with animal models, cell lines, an ongoing Natural History Study and an engaged patient advocacy organization;Therapeutic Advances in Rare Disease;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3